- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01184651
Tweens to Teens Project at Penn State (T2T@PSU)
"Gender Development in Early Adolescence: Prenatal Hormones and Family Socialization"
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Interviewers will visit girls in their home when it is convenient for the family. Girls will answer questions about the things they do and are interested in, how they think and feel, and complete some cognitive tasks. Girls will also provide saliva so we can examine their hormones and determine the CAH gene mutation they have. Parents will also be asked to complete questionnaires about their own activities and interests and about their daughter's behavior.
Shortly after the home visit, interviewers will telephone girls and their parents on several days and ask what the girls did during the day.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- The Pennsylvania State University, Dept. of Psychology - Tweens to Teens Project
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Girls with classical or non-classical CAH due to 21-OHD
- Girls will be aged 10-13 years at initial recruitment
- Parents will include biological mothers and fathers as well as step-parents and/or other guardians/significant caregivers
- Parents/guardians may range in age from 18 years of age to 65 years of age.
Exclusion Criteria:
- Girls who are not within the age range of 10-13 years old at initial recruitment
- CAH not due to the 21-OHD form
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Girls
Girls with 21-hydroxylase deficiency (21-OHD) congenital adrenal hyperplasia (CAH) ages 10-13
|
Girls answer questions about activities and interests, school, feelings about being a girl, stage of physical development, and family relationships during a home interview , provide saliva samples, and participate in phone interviews to answer questions about daily activities .
Parents complete questionnaires about their daughter's activities, interests, and behaviors, educational goals, family demographics and relationships, grades, diagnosis and treatment of her CAH, their own activities, interests, and thoughts and feelings about being male or female.
Parents answer questions during phone interviews about their daughters daily activities.
|
|
Parents
Parent, guardian, or significant caretaker of girls with CAH
|
Girls answer questions about activities and interests, school, feelings about being a girl, stage of physical development, and family relationships during a home interview , provide saliva samples, and participate in phone interviews to answer questions about daily activities .
Parents complete questionnaires about their daughter's activities, interests, and behaviors, educational goals, family demographics and relationships, grades, diagnosis and treatment of her CAH, their own activities, interests, and thoughts and feelings about being male or female.
Parents answer questions during phone interviews about their daughters daily activities.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sheri A Berenbaum, PhD, The Pennsylvania State University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Metabolic Diseases
- Endocrine System Diseases
- Gonadal Disorders
- Disorders of Sex Development
- Urogenital Abnormalities
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Metabolism, Inborn Errors
- Adrenal Gland Diseases
- Steroid Metabolism, Inborn Errors
- Hyperplasia
- Adrenal Hyperplasia, Congenital
- Adrenogenital Syndrome
Other Study ID Numbers
- PSU ORP#30695
- 1R01HD057930-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.